HIT vendors eager to advance the cause of shareable clinical information – and their products – can do so this Spring in a first-of-a-kind interoperability demonstration. ASCO is not primarily a trade or HIT show. It is the central venue for 25,000+ cancer clinicians, researchers, and other stakeholders from around the world. This makes the ASCO Annual Meeting distinct from an HIT conference like HIMSS, the great-grand-daddy of HIT venues and interoperability demonstrations. Does that make it more attractive or less attractive as a site to show off your interoperability chops? As a first-ever event, we can’t promise, but we think it is potentially awesome. While HIMSS is great for more reasons than we can list, demonstrating at a scientific/clinical conference like ASCO has some advantages: This will be the only HIT demonstration of its kind at the conference.
- It has the full support, sponsorship, branding, and marketing of the host organization.
- Placed in the middle of the show floor, in a theatre setting, there will be high exposure.
- Participation is limited, selection criteria are rigorous.
- Show how HIT can improve coordination and quality of care.
- Highlight use of oncology-specific and other open interoperability standards.
- Demonstrate how HIT can link the care team with the patient.
- Reuse clinical data for research, decision support, public health, reimbursement.